Stock listing

Geron Corporation

Selected listing: 902213 · LS · EUR · DE

Geron Corporation (Lang & Schwarz: 902213), Health Technology. Latest release Aug 5, 2026: Geron Corporation Reports Second Quarter 2026 Financial Results…

902213:LSEURDEUpdated September 25, 2026

Ticker: Lang & Schwarz: 902213
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Lang & Schwarz
Currency: EUR

About Geron Corporation

The company focuses on developing innovative therapies for cancer treatment. Geron is committed to advancing its research and development efforts to address unmet medical needs in oncology.

Latest news from Geron Corporation

Geron Corporation Reports Second Quarter 2026 Financial Results and Recent Business Highlights

August 5, 2026

Geron Plans to Announce Second Quarter 2026 Financial Results on August 5, 2026

July 22, 2026

Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - July 14, 2026

July 15, 2026

Geron Announces Appointment of Chinmaya Rath as Chief Business Officer

July 13, 2026

Geron Corporation Reports Inducement Grants under Nasdaq Listing Rule 5635(4)

June 19, 2026

All Geron Corporation news →

Events

Replays

Geron Corporation (GERN) Q2 2026 Earnings Call
Wed, Aug 05, 2026 · 08:00 AM ET
Watch
Geron Corporation (GERN) Q1 2026 Earnings Call
Wed, May 06, 2026 · 08:00 AM ET
Watch
Geron Corporation (GERN) Q4 2025 Earnings Call
Wed, Feb 25, 2026 · 08:00 AM ET
Watch

Research Geron Corporation

Geron Corporation company profile

View the public company page for Geron Corporation on 6ix.

Geron Corporation news

Read company news and market updates connected to Geron Corporation.

Geron Corporation investor events

Find investor webinars, events, and replay context for Geron Corporation.